Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-22 Purchase |
2024-11-26 4:15 pm |
Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director |
1,123,595 | $0 | $0 | 2,997,394 (Direct) |
View |
| 2023-08-16 Purchase |
2023-08-16 8:53 pm |
Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director |
777,778 | $0.9 | $700,000 | 1,933,671 (Indirect Direct) |
View |
| 2022-07-05 Purchase |
2022-07-05 4:11 pm |
Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director |
238,095 | $2.1 | $500,000 | 700,205 (Direct) |
View |
| 2021-07-06 Purchase |
2021-07-08 6:17 pm |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
35,000 | $16 | $560,000 | 303,919 (Indirect Direct) |
View |
| 2020-08-13 Purchase |
2020-08-17 4:39 pm |
Verrica Pharmaceuticals Inc. | VRCA | Stalfort Sean Director |
31,250 | $6.4148 | $200,464 | 462,110 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-26 Gift |
2024-11-26 4:15 pm |
N/A N/A |
Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director |
50,000 | $0 | 2,997,394 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:49 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 4:18 pm |
N/A 2034-05-29 |
Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director |
147,660 | $0 | 2,081,331 (Direct) |
View |
| 2023-08-16 Gift |
2023-08-16 8:53 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director |
50,000 | $0 | 1,933,671 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 4:48 pm |
N/A 2033-06-22 |
Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director |
43,800 | $0 | 43,800 (Direct) |
View |
Ownership |
2023-06-26 4:46 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Stalfort John A III Director |
0 | $0 | 1,105,893 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 5:45 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:24 pm |
N/A 2032-06-14 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 6:17 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
261,775 | $0 | 303,919 (Direct) |
View |
Ownership(A) |
2021-07-08 5:59 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
0 | $0 | 131,595 (Indirect) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:20 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
34,000 | $0 | 34,000 (Direct) |
View |
Ownership |
2021-06-30 6:59 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
0 | $0 | 137,324 (Direct) |
View |